Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $5.8500 (-1.68%) ($5.7800 - $6.0500) on Thu. Dec. 15, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.12% (three month average) | RSI | 41 | Latest Price | $5.8500(-1.68%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -0.5% a day on average for past five trading days. | Weekly Trend | CGEN advances 0.1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) EWG(4%) IPO(4%) TBT(4%) URA(4%) EWI(2%) | Factors Impacting CGEN price | CGEN will decline at least -1.06% in a week (0% probabilities). VCSH(-9%) VCIT(-9%) BNDX(-8%) USO(-7%) TIP(-7%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.06% (StdDev 2.12%) | Hourly BBV | 0 () | Intraday Trend | -1.7% | | | |
|
Resistance Level | $6.11 | 5 Day Moving Average | $6.08(-3.78%) | 10 Day Moving Average | $6.03(-2.99%) | 20 Day Moving Average | $6.11(-4.26%) | To recent high | -14.1% | To recent low | 4.5% | Market Cap | $484m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |